Regeneration of cardiac muscle for the treatment of heart failure

Case ID:
C16843

Value Proposition:

  • This technology provides a therapeutic approach for the regrowth of permanently damaged heart muscle.
  • This could improve health outcomes for patients with severe heart failure.

Technology Description

Researchers at Johns Hopkins have discovered that the manipulation of circadian genes can induce the proliferation and regeneration of cardiomyocytes (cardiac muscle cells). Sympathetic neuron activity in the heart upregulates the production of period circadian (PER) proteins. PER proteins regulate mitosis in cardiomyocytes, inhibiting Cdk1 via the Wee1 kinase pathway. Inhibition of PER proteins allows cardiomyocytes to enter mitosis, which leads to increased proliferation and regeneration.

 

Unmet Need

Heart disease is the leading cause of death in the United States [1]. Heart failure arises when cardiomyocytes die (e.g., post-heart attack), as these cells have limited capacity for regeneration [2]. They are instead replaced by d by fibrous tissue, resulting in a gradual loss of heart function [3]. The standard-of-care in cases of severe heart failure is organ transplant [4], which carries significant risk [5]. There are no regenerative therapies currently available for heart failure. Therefore, there is a strong need to develop therapeutics aimed at cardiomyocyte regeneration to improve health outcomes for patients with heart failure.

 

Stage of Development

PER inhibition has been tested in healthy animal models and in cardiomyocytes in vitro; currently evaluating in animal models post-myocardial infarction and/or heart failure.

 

Publication

Tampakakis, E., Gangrade, H., Glavaris, S., Htet, M., Murphy, S., Lin, B. L., Liu, T., Saberi, A., Miyamoto, M., Kowalski, W., Mukouyama, Y. S., Lee, G., Minichiello, L., & Kwon, C. (2021). Heart neurons use clock genes to control myocyte proliferation. Science advances, 7(49), eabh4181. https://doi.org/10.1126/sciadv.abh4181

 

Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
METHODS AND MATERIALS FOR TREATING HEART ATTACK PCT: Patent Cooperation Treaty United States 18/726,381   7/2/2024     Pending
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum